Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$24.74 - $35.13 $1,979 - $2,810
-80 Reduced 0.25%
32,296 $871,000
Q4 2023

Jan 16, 2024

SELL
$21.62 - $37.21 $93,376 - $160,709
-4,319 Reduced 11.77%
32,376 $1.16 Million
Q3 2023

Oct 30, 2023

SELL
$27.34 - $55.37 $33,737 - $68,326
-1,234 Reduced 3.25%
36,695 $1.04 Million
Q2 2023

Aug 07, 2023

SELL
$26.1 - $49.92 $33,381 - $63,847
-1,279 Reduced 3.26%
37,929 $1.89 Million
Q1 2023

Apr 14, 2023

BUY
$18.09 - $27.61 $22,033 - $33,628
1,218 Added 3.21%
39,208 $1.03 Million
Q4 2022

Jan 24, 2023

SELL
$16.24 - $26.38 $68,110 - $110,637
-4,194 Reduced 9.94%
37,990 $0
Q3 2022

Nov 08, 2022

SELL
$23.95 - $34.71 $6,777 - $9,822
-283 Reduced 0.67%
42,184 $1.05 Million
Q2 2022

Jul 28, 2022

SELL
$21.39 - $35.9 $61,175 - $102,674
-2,860 Reduced 6.31%
42,467 $1.12 Million
Q1 2022

Apr 22, 2022

SELL
$24.84 - $36.12 $440,413 - $640,407
-17,730 Reduced 28.12%
45,327 $1.55 Million
Q4 2021

Feb 01, 2022

SELL
$33.38 - $59.25 $328,425 - $582,960
-9,839 Reduced 13.5%
63,057 $2.2 Million
Q3 2021

Nov 05, 2021

SELL
$53.75 - $76.55 $103,522 - $147,435
-1,926 Reduced 2.57%
72,896 $3.99 Million
Q2 2021

Jul 30, 2021

SELL
$59.02 - $78.8 $175,171 - $233,878
-2,968 Reduced 3.82%
74,822 $5.66 Million
Q1 2021

May 12, 2021

SELL
$64.61 - $113.09 $36.9 Million - $64.6 Million
-570,942 Reduced 88.01%
77,790 $5.93 Million
Q1 2021

May 04, 2021

BUY
$64.61 - $113.09 $36.6 Million - $64.1 Million
566,839 Added 692.17%
648,732 $49.5 Million
Q4 2020

Feb 03, 2021

SELL
$48.06 - $84.4 $836,292 - $1.47 Million
-17,401 Reduced 17.52%
81,893 $6.48 Million
Q3 2020

Nov 12, 2020

BUY
$46.87 - $93.33 $4.65 Million - $9.27 Million
99,294 New
99,294 $4.72 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.22B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.